Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 3 crawled date : 2021 - 11 - 15 save search
PhaseBio Announces Interim Results from Pivotal REVERSE-IT Phase 3 Trial of Bentracimab for the Reversal of Antiplatelet Effects of Ticagrelor in Patients Requiring Urgent Surgery or Experiencing Uncontrolled Major or Life-Threatening Bleeding
Published: 2021-11-15 (Crawled : 17:00) - biospace.com/
PHAS | $0.0701 -23.97%
|
Health Technology
|
| O: 1.35%
H: 8.8%
C: -19.47%
bleeding results phase 3 trial bentracimab
AnaptysBio Announces Positive Rosnilimab Healthy Volunteer Phase 1 Top-Line Data
Published: 2021-11-15 (Crawled : 14:00) - ir.anaptysbio.com
ANAB | $18.83 -1.83% 99K
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
phase 1 positive topline phase 2 phase 3
Celcuity Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Provide Ibrance(R) (palbociclib) for Planned Phase 3 Clinical Trial
Published: 2021-11-15 (Crawled : 13:30) - biospace.com/
CELC | $17.01 -1.33% 34K
|
Commercial Services
|
| O: -4.0%
H: 1.15%
C: 1.15%
collaboration phase 3 trial
Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial of RP-A501 in Danon Disease
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
RCKT 4 | $23.525 -0.61% 510K
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: -23.94%
disease phase 1 positive trial phase 2 phase 3 rp-a501 danon disease
GlycoMimetics Completes Enrollment of Phase 3 Registration Trial Evaluating Lead Candidate Uproleselan in Patients with Relapsed /Refractory Acute Myeloid Leukemia (AML)
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
GLYC | $1.8 -1.91% 370K
|
Health Technology
|
| O: 0.47%
H: 2.8%
C: 0.0%
myeloid leukemia leukemia phase 3 trial enroll acute myeloid leukemia aml
Oyster Point Pharma Announces Publication in Ophthalmology of ONSET-2 Phase 3 Data on TYRVAYAᵀᴹ (varenicline solution) Nasal Spray
Published: 2021-11-15 (Crawled : 12:00) - globenewswire.com
OYST | $11.17 0.18% -0.27%
|
Health Technology
|
| O: 3.5%
H: 1.26%
C: -8.17%
nasal spray phase 3
Addex Strategic Partner Successfully Completes Phase 1 in Japan with ADX71149
Published: 2021-11-15 (Crawled : 09:00) - biospace.com/
JNJ | News | $148.515 -0.7% 4.3M
|
Health Technology
|
| O: -1.36%
H: 0.0%
C: 0.0%
ADXN | $18.74 8.9K
|
Health Technology
|
| O: 2.85%
H: 1.14%
C: 1.14%
phase 1 phase 2 xin phase 3
Late Breaking Presentation at American Heart Association Annual Meeting of Landmark Phase 3 Trial of Rexlemestrocel-L in Chronic Heart Failure
Published: 2021-11-15 (Crawled : 01:00) - globenewswire.com
MESO | $6.14 2.33% 140K
|
Health Technology
|
| O: 7.99%
H: 0.0%
C: 0.0%
presentation heart phase 3 trial
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.85 51.79% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
SKIL 4 | $8.045 40.89% 230K
|
Information
MULN | News | $3.805 39.38% 11M
|
Information
RILY | $30.01 38.17% 11M
|
Finance
MTC | $3.04 35.71% 6.7M
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.